NCT00019123View on ClinicalTrials.gov

Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 1996

Study Completion Date

April 30, 2004

Conditions

Sarcoma

Interventions

DRUG

thalidomide

Trial Locations (1)

20892

Medicine Branch, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00019123 - Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter